Tests confirmed the compounds halted the virus and stopped it from replicating without damage to host mammalian cells, researchers said.
"Our plaque assays found that the extract from this fairly common native plant killed 100 per cent of the Zika infection in cells," said lead researcher Trudi Collet from Queensland University of Technology (QUT) in Australia.
"It is also exciting because of the implications of this work for other viruses. Zika, Dengue, West Nile, Japanese Encephalitis and Yellow Fever are all from the same family of viruses - flaviviridae," Collet said.
According to USA Centres for Disease Control and Prevention (CDC), there was a 20-fold increase in the number of birth defects in women infected with Zika last year, researchers said.
"Zika is becoming more prevalent in developed countries and, once contracted, the virus has been shown to remain in human sperm for six months," said Mark Baldock, chairman, Health Focus Products Australia (HFPA), which collaborated with QUT for the study.
"This breakthrough brings new hope that we could one day eliminate the virus from people who contract it in the very early stages and remove that prolonged danger and uncertainty," said Baldock.
Zika is a virus that is closely related to dengue and is spread by mosquitoes and by human sexual activity.
While most people experience a very mild infection without any complications, recent outbreaks of the Zika virus in the Pacific and the Americas show that it can be passed from a woman to her unborn baby and potentially cause serious birth defects.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
